National Oxygen (BSE 507813)₹59.39+1.63%Industrial Gases
In the Mar 2026 quarter (standalone), National Oxygen reported sales of ₹3.99 Cr, down 53.9% from Mar 2025, and net profit of −₹1.77 Cr. For the year to Mar 2026, sales were ₹23.05 Cr and net profit ₹1.83 Cr.
Company filings, standalone accounts; latest reported quarter Mar 2026
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 11.16 | 11.85 | 11.33 | 11.05 | 10.61 | 10.65 | 10.81 | 8.65 | 7.60 | 6.39 | 5.06 | 3.99 |
| Expenses | 10.62 | 11.34 | 11.34 | 10.81 | 10.59 | 10.57 | 11.56 | 10.42 | 8.63 | 6.83 | 5.78 | 5.08 |
| Operating Profit | 0.52 | 0.49 | −0.01 | 0.22 | 0.00 | 0.05 | −0.75 | −1.77 | −1.02 | −0.44 | −0.72 | −1.09 |
| OPM % | 4.8% | 4.3% | −0.2% | 2.1% | 0.0% | 0.6% | −7.0% | −20.6% | −13.5% | −7.0% | −14.4% | −27.7% |
| Other Income | 0.05 | 0.11 | 0.05 | 0.25 | 0.05 | 0.07 | 0.06 | 0.06 | 0.04 | 8.36 | 0.10 | 0.34 |
| Interest | 0.36 | 0.42 | 0.43 | 0.47 | 0.44 | 0.47 | 0.43 | 0.29 | 0.29 | 0.31 | 0.37 | 0.49 |
| Depreciation | 0.81 | 0.81 | 0.82 | 0.86 | 0.86 | 0.86 | 0.86 | 0.60 | 0.60 | 0.57 | 0.56 | 0.55 |
| Profit before tax | −0.59 | −0.62 | −1.22 | −0.85 | −1.25 | −1.20 | −1.99 | −2.61 | −1.88 | 7.07 | −1.56 | −1.80 |
| Tax % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 8.14 | 0.00 | 0.00 |
| Net Profit | −0.57 | −0.59 | −1.20 | −0.83 | −1.24 | −1.18 | −1.97 | −2.58 | −1.86 | 7.02 | −1.54 | −1.77 |
| EPS (Rs) | −1.20 | −1.24 | −2.51 | −1.66 | −2.47 | −2.35 | −3.92 | −5.12 | −3.70 | 13.92 | −3.06 | −3.52 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 33.31 | 36.19 | 41.49 | 46.35 | 44.09 | 39.91 | 50.81 | 47.30 | 45.38 | 40.72 | 23.05 | 23.04 |
| Expenses | 30.44 | 31.54 | 35.79 | 37.69 | 37.61 | 33.55 | 39.29 | 43.50 | 44.09 | 43.14 | 26.32 | 26.32 |
| Operating Profit | 2.80 | 4.59 | 5.61 | 8.57 | 6.38 | 6.26 | 11.41 | 3.67 | 1.23 | −2.46 | −3.31 | −3.27 |
| OPM % | 8.5% | 12.8% | 13.7% | 18.6% | 14.6% | 15.9% | 22.7% | 7.8% | 2.8% | −6.0% | −14.4% | −14.2% |
| Other Income | 0.34 | 0.32 | 2.18 | 3.41 | 0.26 | 0.39 | 1.43 | 0.58 | 0.49 | 0.27 | 8.86 | 8.84 |
| Interest | 6.11 | 6.47 | 5.91 | 4.91 | 4.81 | 4.49 | 2.16 | 1.80 | 1.65 | 1.60 | 1.42 | 1.46 |
| Depreciation | 3.92 | 3.90 | 3.78 | 3.52 | 3.40 | 3.27 | 3.08 | 3.26 | 3.32 | 3.21 | 2.30 | 2.28 |
| Profit before tax | −6.90 | −5.45 | −1.89 | 3.58 | −1.56 | −1.10 | 7.66 | −0.80 | −3.24 | −7.03 | 1.85 | 1.83 |
| Tax % | −17.2% | −0.6% | −0.5% | 0.0% | 0.7% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Exceptional items | 0.05 | 0.05 | 1.91 | 3.30 | 0.05 | 0.04 | 1.11 | 0.00 | 0.06 | 0.02 | 8.14 | 8.14 |
| Net Profit | −5.66 | −5.39 | −1.86 | 3.55 | −1.56 | −1.09 | 7.60 | −0.78 | −3.22 | −6.98 | 1.83 | 1.85 |
| EPS (Rs) | −11.80 | −11.24 | −3.88 | 7.39 | −3.26 | −2.28 | 15.84 | −1.64 | −6.39 | −13.84 | 3.64 | 3.64 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4.80 | 4.80 | 4.80 | 4.81 | 4.81 | 4.81 | 4.81 | 4.81 | 4.80 | 5.05 | 5.05 | 5.05 |
| Reserves | 1.34 | −4.37 | −11.48 | −13.34 | −9.77 | −11.36 | −12.44 | −4.80 | −5.74 | −6.05 | −13.08 | −11.18 |
| Borrowings | 43.22 | 48.30 | 48.95 | 44.02 | 38.07 | 38.57 | 37.19 | 32.76 | 29.02 | 28.62 | 30.66 | 28.66 |
| Other Liabilities | 7.84 | 6.97 | 6.71 | 6.34 | 6.01 | 6.13 | 6.36 | 6.94 | 6.75 | 6.42 | 8.37 | 5.70 |
| Total Liabilities | 57.20 | 55.70 | 48.98 | 41.83 | 39.12 | 38.15 | 35.92 | 39.71 | 34.83 | 34.04 | 31.00 | 28.23 |
| Fixed Assets | 48.65 | 44.76 | 39.71 | 35.16 | 31.83 | 28.95 | 26.41 | 24.20 | 22.02 | 21.91 | 19.52 | 18.40 |
| CWIP | 0.00 | 0.00 | 0.04 | 0.04 | 0.04 | 0.04 | 0.07 | 0.00 | 0.15 | 0.82 | 0.19 | 3.31 |
| Investments | 0.55 | 0.15 | 0.00 | 0.10 | 0.18 | 0.18 | 0.22 | 0.11 | 0.04 | 0.09 | 0.32 | 0.17 |
| Other Assets | 8.00 | 10.79 | 9.23 | 6.53 | 7.07 | 8.98 | 9.22 | 15.40 | 12.62 | 11.22 | 10.97 | 6.35 |
| Inventories | 0.57 | 0.67 | 0.31 | 0.23 | 0.27 | 0.47 | 0.64 | 0.90 | 1.13 | 1.02 | 0.94 | 0.64 |
| Trade receivables | 3.59 | 6.03 | 4.48 | 3.72 | 4.23 | 4.89 | 5.01 | 5.05 | 5.35 | 5.29 | 3.25 | 1.79 |
| Cash & equivalents | 0.80 | 0.81 | 0.54 | 0.82 | 0.92 | 1.06 | 1.02 | 6.48 | 2.16 | 0.50 | 0.57 | 0.56 |
| Total Assets | 57.20 | 55.70 | 48.98 | 41.83 | 39.12 | 38.15 | 35.92 | 39.71 | 34.83 | 34.04 | 31.00 | 28.23 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 1.29 | 1.48 | 4.86 | 8.44 | 7.83 | 4.82 | 6.51 | 11.56 | 2.22 | 0.96 | −0.17 | −1.08 |
| Cash from investing activity | −1.66 | −0.44 | 0.70 | 2.67 | 3.11 | −0.38 | −0.69 | 0.39 | −0.61 | −3.68 | −0.20 | 4.54 |
| Cash from financing activity | 0.40 | −1.04 | −5.86 | −10.88 | −10.88 | −4.31 | −5.88 | −6.55 | −5.94 | 1.08 | 0.46 | −3.48 |
| Net cash flow | 0.01 | 0.00 | −0.26 | 0.27 | 0.10 | 0.13 | −0.03 | 5.44 | −4.30 | −1.65 | 0.06 | 0.00 |
| Capex | 1.36 | 0.06 | 0.05 | 0.11 | 0.44 | 0.54 | 0.80 | 0.96 | 0.86 | 3.92 | 0.21 | 4.64 |
| Free cash flow | 0.06 | 1.49 | 4.89 | 11.18 | 10.97 | 4.36 | 5.76 | 11.92 | 1.39 | −2.90 | −0.38 | 3.12 |
| CFO / OP % | −92.0% | 53.9% | 106.0% | 150.0% | 92.0% | 76.0% | 103.9% | 102.0% | 62.0% | 82.9% | 6.0% | 30.9% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 48 | 67 | 46 | 34 | 34 | 42 | 47 | 37 | 42 | 44 | 30 | 29 |
| Cash conversion cycle | 48 | 67 | 46 | 34 | 34 | 42 | 47 | 37 | 42 | 44 | 30 | 29 |
| Working capital days | −159 | −98 | −99 | −82 | −50 | −28 | −29 | 2 | 11 | −17 | −45 | −99 |
| ROCE % | −10.5% | −1.7% | 2.1% | 5.4% | 15.0% | 9.8% | 10.8% | 27.7% | 3.3% | −5.9% | −21.6% | −21.6% |
For the Mar 2026 quarter, National Oxygen reported sales of ₹3.99 Cr, down 53.9% year on year and net profit of −₹1.77 Cr. The operating margin was −27.7%.
National Oxygen's sales for the year to Mar 2026 were ₹23.05 Cr; over the last twelve months they were ₹23.04 Cr.
Net profit for the year to Mar 2026 was ₹1.83 Cr, and ₹1.85 Cr over the last twelve months. Earnings per share over the same trailing period were ₹3.64.
National Oxygen reported borrowings of ₹28.66 Cr at Mar 2026, against cash and equivalents of ₹0.56 Cr.
Cash from operations was −₹1.08 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹3.12 Cr.